Class IITerminatedD-0509-2024
Drug recall · June 5, 2024
Cathflo activase recall
Why: Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64
- Lots / codes
Lot #: 3618858, 3618873, Exp. Date 01/31/2026
- Quantity
- Lot:3618858 = 105,759; Lot:3618873 =90,359
- Company
- Genentech, Inc., South San Francisco, CA
- Distribution
- Nationwide within the United States
- Initiated
- May 20, 2024 · Voluntary: Firm initiated
- Classified
- May 24, 2024
- Reported
- June 5, 2024
- Ended
- August 11, 2025
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.